Search Results

Showing results 9971 - 9980 for presbyterian cornell

Residency Program Overview | Pediatrics

...Bernhard Kühn Named Chief of the Division of Cardiology in Pediatrics at Weill Cornell Medicine and NewYork-Presbyterian...

https://pediatrics.weill.cornell.edu/education/residency-program/residency-program-overview

Head-to-Head Trial Compares Weight Loss Drugs | Government & Community Affairs

...In the 72-week trial—led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian and conducted...

https://gca.weill.cornell.edu/news/head-head-trial-compares-weight-loss-drugs

Keeping Pediatrics Afloat in a Sea of Funding Cuts | Government & Community Affairs

...Weill Cornell Medicine © Weill Cornell Medicine....

https://gca.weill.cornell.edu/news/keeping-pediatrics-afloat-sea-funding-cuts

Microsoft PowerPoint - Alumni Day 2024 Booklet Draft

...from Princeton University, his MD from Columbia University, was an intern and resident at Columbia Presbyterian...

https://eye.weillcornell.org/sites/default/files/alumni_day_2024_booklet.pdf

Understanding the Origins of Hodgkin Lymphoma Cells Could Lead to Better Diagnostics | Government & Community Affairs

...Cesarman, who is also a pathologist at NewYork-Presbyterian/Weill Cornell Medical Center....

https://gca.weill.cornell.edu/news/understanding-origins-hodgkin-lymphoma-cells-could-lead-better-diagnostics

A Phase 3b/4 Randomized, Open-label, Efficacy Assessor-Blinded Study, to Evaluate the Efficacy and Safety of Upadacitinib for the Treatment of Adult Subjects with Moderate to Severe Atopic Dermatitis (AD) and Inadequate Response to Dupilumab (SWITCH-UP) | Joint Clinical Trials Office

...Weill Cornell Medicine NewYork - Presbyterian © Weill Cornell Medicine....

https://jcto.weill.cornell.edu/open_clinical_trials/a-phase-3b4-randomized-open-label-efficacy-assessor-blinded-study-to-evaluate-the-efficacy-and-safety-of-upadacitinib-for-the-treatment-of-adult-subjects-with-moderate-to-severe-atopic-dermatitis-ad-and-inadequate-response-to

Dr. Mark Souweidane Reaches Milestone of 300 Endoscopic Colloid Cyst Resections | Neurological Surgery

...NewYork-Presbyterian and Weill Cornell Medicine offer a rare comprehensive team that includes specific...

https://neurosurgery.weill.cornell.edu/about-us/news-updates/dr-mark-souweidane-reaches-milestone-300-endoscopic-colloid-cyst-resections-0

AREN2231: Risk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors (FHWT) | Joint Clinical Trials Office

...Weill Cornell Medicine NewYork - Presbyterian © Weill Cornell Medicine....

https://jcto.weill.cornell.edu/open_clinical_trials/aren2231-risk-adapted-treatment-of-unilateral-favorable-histology-wilms-tumors-fhwt

A New Kind of Cold Sensor | Department of Cell & Developmental Biology

...Weill Cornell Medicine NewYork - Presbyterian © Weill Cornell Medicine....

https://celldevbiology.weill.cornell.edu/news-and-updates/new-kind-cold-sensor

A parting shot at cancer | Sandra and Edward Meyer Cancer Center

...Patients enrolled in precision medicine clinical trials at Weill Cornell Medicine/NewYork-Presbyterian...

https://meyercancer.weill.cornell.edu/news/2017-06-22/parting-shot-cancer

Showing results 9971 - 9980 for presbyterian cornell